Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Actinium Pharmaceuticals’ ATNM-400 shows superior anti-tumor activity
10h ago
AZN
JNJ
Premium
The Fly
AstraZeneca assumed with a Buy at Jefferies
11h ago
AZN
Premium
The Fly
Trump Trade: Trump administration prepares new probe into pharma prices
5d ago
CI
AZN
Premium
The Fly
AstraZeneca, Amgen’s Tezspire approved in EU as add-on therapy
5d ago
AZN
AMGN
Premium
The Fly
Trump admin prepares new probe into U.S. pharma prices, FT says
5d ago
CI
AZN
Premium
Company Announcements
AstraZeneca’s Tezspire Gains EU Approval for Chronic Rhinosinusitis with Nasal Polyps
6d ago
Premium
Company Announcements
AstraZeneca’s Tezspire Gains FDA Approval for New Indication
8d ago
Premium
Company Announcements
AstraZeneca’s Saphnelo Recommended for EU Approval in Self-Administration Form
8d ago
Premium
The Fly
AstraZeneca, Daiichi announce results from DESTINY-Breast11 Phase III trial
8d ago
AZN
Premium
The Fly
AstraZeneca, Daiichi Sankyo announce Enhertu demonstrated improvement in IDFS
8d ago
AZN
Premium
The Fly
AstraZeneca, Daiichi’s Datroway demonstrated significant improvement in OS, PFS
8d ago
AZN
Premium
The Fly
AstraZeneca announces improvements in pCR rate in DESTINY-Breast11 trial
8d ago
AZN
Premium
The Fly
AstraZeneca, Daiichi announce ENHERTU showed improvement in IDFS
8d ago
AZN
Premium
The Fly
Amgen, AstraZeneca announce FDA approval of Tezspire
10d ago
AZN
AMGN
Premium
The Fly
AstraZeneca’s Saphnelo recommended for approval in EU
10d ago
AZN
Premium
The Fly
AstraZeneca announces results from POTOMAC Phase III trial
10d ago
AZN
Premium
The Fly
AstraZeneca announces IMFINZI improvement in secondary endpoint of OS
10d ago
AZN
Premium
The Fly
Personalis announces NeXT Personal data from AstraZeneca’s Phase 3 LAURA trial
11d ago
AZN
PSNL
Premium
The Fly
Merck reports Phase 3 ovarian cancer trial meets survival endpoint
11d ago
AZN
MRK
Premium
The Fly
AstraZeneca downgraded to Sell from Hold at Deutsche Bank
12d ago
AZN
Premium
The Fly
AstraZeneca unveils manufacturing facility in Texas
12d ago
AZN
Premium
The Fly
Trump Trade: U.S. to impose 100% additional tariff on Chinese goods
14d ago
BA
AZN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
